NOV (NOV) Earnings Analysis

NOV (NOV) has no confirmed upcoming earnings date. Last quarter (2026-04-27) it missed with EPS 0.05 USD vs 0.17 USD est (-70.6%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E 84.71.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NOV next report earnings?

No confirmed upcoming earnings date is currently scheduled for NOV. This page updates as the calendar is published.

NOV earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-270.05 USD0.17 USD-70.6%Miss
2026-02-040.02 USD0.25 USD-92%Miss
2025-10-270.11 USD0.24 USD-54.2%Miss
2025-07-280.29 USD0.3 USD-3.3%Miss
2025-04-280.19 USD0.2496 USD-23.9%Miss
2024-10-240.33 USD0.36 USD-8.3%Miss
2024-07-250.57 USD0.35 USD+62.9%Beat

Beat rate: 1/7 (14%) over reported quarters with consensus data.

NOV valuation and analyst view

Trailing P/E84.71
Trailing EPS0.25485 USD
Price / book1.18
Dividend yield2.07%
Market cap7.26B
Analyst consensusHold (25 buy / 30 hold / 3 sell)
Avg price target22.17 USD

Related research pages

Frequently asked questions

When is NOV (NOV)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for NOV. This page updates as the calendar is published.

Did NOV beat earnings last quarter?

In its 2026-04-27 report, NOV posted EPS of 0.05 USD versus a 0.17 USD estimate — a miss of 70.6%.

What is NOV's earnings track record?

Over the last 7 reported quarters with consensus data, NOV beat estimates 1 times (14%).

What is NOV's current P/E ratio and EPS?

NOV trades at a trailing P/E of 84.71 on trailing EPS of 0.2548476454293629 USD.

What do analysts rate NOV?

Analyst consensus is "Hold" across 58 ratings (0 strong buy, 25 buy, 30 hold, 3 sell, 0 strong sell). Average 12-month price target: 22.17 USD.